Johannes Karges develops anti-cancer agents that work in a targeted manner, rather than adversely affecting the entire body.
Groundbreaking malaria vaccine provides high-level protection with just one dose
Scientists at Sanaria and Seattle Children’s Research Institute’s Center for Global Infectious Disease Research (CGIDR) have unveiled a groundbreaking malaria vaccine, Sanaria® PfSPZ-LARC2 Vaccine, designed